BioXcel Therapeutics Inc
Quick facts
Marketed products
- Sublingual film containing Igalmi · Psychiatry
Igalmi is a fast-acting atypical antipsychotic that rapidly dissolves under the tongue to block dopamine and serotonin receptors in the brain.
Phase 3 pipeline
- Placebo film
A placebo film formulation serves as an inert control comparator in clinical trials to assess the efficacy of active pharmaceutical agents.
Phase 2 pipeline
- BXCL501 Sublingual Film · Neurology
BXCL501 is a selective serotonin reuptake inhibitor (SSRI) that modulates serotonin levels in the brain to treat acute agitation.
Phase 1 pipeline
- BXCL501 120 Micrograms
- BXCL501 60 Micrograms
- BXCL501 80 Micrograms
- BXCL701 monotherapy
- BXCL701 plus Pembrolizumab
- Sublingual film containing Dexmedetomidine
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: